Our observations provide new insights into the contribution of the CD200-CD200R1 inhibitory pathway to the progression of neuroimmune dysfunction following stroke and highlight a novel role for CD200R1 for the prevention of systemic immunosuppression and secondary infection after stroke. Here, CD200R1 is linked to stroke disorder.